| Literature DB >> 32455711 |
Marie-Noëlle Labour1,2,3, Camile Le Guilcher1,2, Rachida Aid-Launais1,4, Nour El Samad1,2, Soraya Lanouar1,2, Teresa Simon-Yarza1,2, Didier Letourneur1,2.
Abstract
Organoids production is a key tool for in vitro studies of physiopathological conditions, drug-induced toxicity assays, and for a potential use in regenerative medicine. Hence, it prompted studies on hepatic organoids and liver regeneration. Numerous attempts to produce hepatic constructs had often limited success due to a lack of viability or functionality. Moreover, most products could not be translated for clinical studies. The aim of this study was to develop functional and viable hepatic constructs using a 3D porous scaffold with an adjustable structure, devoid of any animal component, that could also be used as an in vivo implantable system. We used a combination of pharmaceutical grade pullulan and dextran with different porogen formulations to form crosslinked scaffolds with macroporosity ranging from 30 µm to several hundreds of microns. Polysaccharide scaffolds were easy to prepare and to handle, and allowed confocal observations thanks to their transparency. A simple seeding method allowed a rapid impregnation of the scaffolds with HepG2 cells and a homogeneous cell distribution within the scaffolds. Cells were viable over seven days and form spheroids of various geometries and sizes. Cells in 3D express hepatic markers albumin, HNF4α and CYP3A4, start to polarize and were sensitive to acetaminophen in a concentration-dependant manner. Therefore, this study depicts a proof of concept for organoid production in 3D scaffolds that could be prepared under GMP conditions for reliable drug-induced toxicity studies and for liver tissue engineering.Entities:
Keywords: 3D scaffold; HepG2; liver; organoid; polysaccharide; tissue engineering
Mesh:
Substances:
Year: 2020 PMID: 32455711 PMCID: PMC7279349 DOI: 10.3390/ijms21103644
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Effect of polysaccharide formulations (porogen type and weight amounts) on scaffold production, phosphorous content (n = 3), swelling ratio (n > 6) and in vitro enzymatic degradation (t1/2, time to degrade 50% of the scaffold weight). Statistical analysis using student t-test. * p < 0.05, ** p < 0.01, *** p < 0.001 denote statistical significance against NaCl scaffold. ## p < 0.01, ### p < 0.001 denote statistical significance against all other scaffolds.
Figure 1Macroscopic and microscopic (SEM) analysis of scaffold structures in dry state. Scaffolds for the five selected formulations were cut vertically to observe by SEM the inner structure under low vacuum mode (40 Pa) at a 20-kV acceleration voltage. Scale bars on SEM pictures are 500 µm. Five representative dry scaffolds placed on a 1 × 1 cm mat are shown in inserts.
Figure 2Hydrogels’ porosity after hydration. (a) Representative confocal microscopy images of the different scaffolds containing Dextran-FITC. Scale bar 200µm. (b) Scaffolds’ porosity calculated from confocal stacks images in A. Statistics were performed using student t-test. Only NaCl scaffold porosity was significantly different than every other one. * p < 0.05, n = 6.
Figure 3HepG2 cell clusters size and conformation in 3D scaffolds after seven days of culture. (a) Confocal image of the interior of scaffolds formed using NaCl (top panel), Na2CO3 (middle panel) or a combination of both porogens (bottom panel). Scaffolds were observed here in green due to 1% Dextran-FITC in the formulations. Cell clusters are shown using phalloidin-TRITC staining. Volume distribution of cell clusters (top right panels) formed within the scaffolds were determined using a 3D semi-automatic analysis using Imaris software. Scale bar: 200µm. (b,c) Distribution of cell clusters volumes (b) and number of cell clusters per mm3 of scaffold (c) represented as box plot using median and 25–75 percentile. Mean volume is represented as a diamond-shape dot, error bars represent standard deviation. (d) Metabolic activity analysed at day one after seeding. Statistical analysis was performed using student t-test. * represent statistical difference towards NaCl scaffolds. # represent statistical difference (p < 0.05) towards Na2CO3-10 scaffolds. All other differences were not significant.
Figure 4Analysis of HepG2 viability and metabolic activity over seven days within NaCl and Na2CO3-10 scaffolds. (a) Cell metabolic activity of HepG2 within NaCl (blue) and Na2CO3-10 (red) scaffolds at day one, four and seven. (b) Percentage of viable cell within NaCl and Na2CO3-10 scaffolds as function of distance from the scaffold surface at day seven. Statistics were performed using ANOVA with Tukey’s post-test. No significant difference was observed. (c) Representative 3D images of live-dead analysis of NaCl (top panel) and Na2CO3 (bottom panel) scaffolds at day seven. Live cells were stained with Calcein AM (green) and dead cells are detected with Ethidium homodimer (red). Scale bar: 200 µm.
Figure 5HepG2 cell functionality in 3D within NaCl and Na2CO3-10 scaffolds. (a) Quantification of albumin secretion in the medium for 24 h after one, four and seven days using ELISA. (b) Quantification of P450 cytochrome CYP3A4 activity overtime. (c) Confocal images (Maximum intensity projection) of typical cell clusters showing the expression of Albumin (red) in the cytoplasm and HNF4α (purple) localized in the nucleus for scaffolds prepared with NaCl (top panel, 30µm total thickness) and Na2CO3-10 (bottom panel, 80µm total thickness) at day seven. (d) Confocal images at day seven (Maximum intensity projection) of typical cell clusters showing the aggregation of Actin (red) in between cells for scaffolds prepared with NaCl (top panel, 49 µm total thickness) and Na2CO3-10 (bottom panel, 94 µm total thickness). (e) Acetaminophen-induced toxicity at day seven on HepG2 cells after 24 h treatment in NaCl and Na2CO3-10 scaffolds. Scale bars: 50 µm. Statistical analysis was performed using ANOVA with Tukey’s post-test. ** p < 0.01, *** p < 0.001.